Literature DB >> 7742267

Effects of administration of captopril, metoprolol, and the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction.

P Di Pasquale, S Paterna, V Bucca, G Licata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7742267     DOI： 10.1007/BF00877407

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  9 in total

1.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.

Authors:  M A Pfeffer; G A Lamas; D E Vaughan; A F Parisi; E Braunwald
Journal:  N Engl J Med       Date:  1988-07-14       Impact factor: 91.245

2.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.

Authors:  R Roberts; W J Rogers; H S Mueller; C T Lambrew; D J Diver; H C Smith; J T Willerson; G L Knatterud; S Forman; E Passamani
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

3.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.

Authors: 
Journal:  Eur Heart J       Date:  1985-03       Impact factor: 29.983

4.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

Authors: 
Journal:  Lancet       Date:  1993-10-02       Impact factor: 79.321

5.  Does captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effects.

Authors:  P Di Pasquale; S Paterna; S Cannizzaro; V Bucca
Journal:  Int J Cardiol       Date:  1994-01       Impact factor: 4.164

6.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

7.  A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction.

Authors:  E G Nabel; E J Topol; A Galeana; S G Ellis; E R Bates; S W Werns; J A Walton; D W Muller; M Schwaiger; B Pitt
Journal:  J Am Coll Cardiol       Date:  1991-02       Impact factor: 24.094

8.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

Authors:  K Swedberg; P Held; J Kjekshus; K Rasmussen; L Rydén; H Wedel
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321
  9 in total
  1 in total

Review 1.  Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.